Jinhe dedicates itself to the development of industrialization technology for Anti-cancer drugs with our own intellectual property rights. Currently Jinhe owns three patents as below:
One of Irinotecan’s Intermediates & its Preparation method and preparation Method Of Irinotecan
Patent Number: ZL 2007 1 004 1525.X
Issue Date: Oct. 27, 2010
 |
A Synthetic method of Docetaxel
Patent Number: ZL 2006 1 0116735.6
Issue Date: 30 July, 2008
 |
A method of irinotecan hydrochloride
Patent Number: ZL2016 1 1234299.2
Issue Date: 8 March, 2019
 |
Jinhe is actively applying other patents by its own technique, aiming at more self-developed intellectual properties to pave the way for long term development. |
